chr17-80117606-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The highest continental population minor allele frequency for c.2338G>A (p.Val780Ile) in gnomAD v2.1.1 is 0.8129 in the South Asian population. This is higher than the ClinGen LSD VCEP’s BA1 threshold (>0.01), therefore meeting the BA1 criterion. There is a ClinVar entry for this variant (Variation ID: 92476; 2 star review status) with six submitters classifying the variant as benign. In summary, this variant meets the criteria to be classified as benign for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LSD VCEP: BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA145769/MONDO:0009290/010

Frequency

Genomes: 𝑓 0.72 ( 39719 hom., cov: 32)
Exomes 𝑓: 0.74 ( 404210 hom. )

Consequence

GAA
NM_000152.5 missense

Scores

1
16

Clinical Significance

Benign reviewed by expert panel U:1B:15

Conservation

PhyloP100: -1.09

Publications

57 publications found
Variant links:
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
GAA Gene-Disease associations (from GenCC):
  • glycogen storage disease II
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
  • glycogen storage disease due to acid maltase deficiency, infantile onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • glycogen storage disease due to acid maltase deficiency, late-onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000152.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
NM_000152.5
MANE Select
c.2338G>Ap.Val780Ile
missense
Exon 17 of 20NP_000143.2P10253
GAA
NM_001079803.3
c.2338G>Ap.Val780Ile
missense
Exon 18 of 21NP_001073271.1P10253
GAA
NM_001079804.3
c.2338G>Ap.Val780Ile
missense
Exon 17 of 20NP_001073272.1P10253

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
ENST00000302262.8
TSL:1 MANE Select
c.2338G>Ap.Val780Ile
missense
Exon 17 of 20ENSP00000305692.3P10253
GAA
ENST00000390015.7
TSL:1
c.2338G>Ap.Val780Ile
missense
Exon 18 of 21ENSP00000374665.3P10253
GAA
ENST00000933406.1
c.2353G>Ap.Val785Ile
missense
Exon 17 of 20ENSP00000603465.1

Frequencies

GnomAD3 genomes
AF:
0.720
AC:
109406
AN:
151932
Hom.:
39700
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.695
Gnomad AMI
AF:
0.648
Gnomad AMR
AF:
0.579
Gnomad ASJ
AF:
0.789
Gnomad EAS
AF:
0.628
Gnomad SAS
AF:
0.810
Gnomad FIN
AF:
0.809
Gnomad MID
AF:
0.851
Gnomad NFE
AF:
0.751
Gnomad OTH
AF:
0.711
GnomAD2 exomes
AF:
0.717
AC:
178198
AN:
248394
AF XY:
0.733
show subpopulations
Gnomad AFR exome
AF:
0.696
Gnomad AMR exome
AF:
0.488
Gnomad ASJ exome
AF:
0.800
Gnomad EAS exome
AF:
0.619
Gnomad FIN exome
AF:
0.797
Gnomad NFE exome
AF:
0.757
Gnomad OTH exome
AF:
0.753
GnomAD4 exome
AF:
0.742
AC:
1083650
AN:
1460334
Hom.:
404210
Cov.:
57
AF XY:
0.746
AC XY:
541672
AN XY:
726500
show subpopulations
African (AFR)
AF:
0.699
AC:
23410
AN:
33470
American (AMR)
AF:
0.501
AC:
22425
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.802
AC:
20960
AN:
26124
East Asian (EAS)
AF:
0.672
AC:
26659
AN:
39694
South Asian (SAS)
AF:
0.808
AC:
69680
AN:
86254
European-Finnish (FIN)
AF:
0.798
AC:
41684
AN:
52238
Middle Eastern (MID)
AF:
0.822
AC:
4733
AN:
5758
European-Non Finnish (NFE)
AF:
0.746
AC:
828904
AN:
1111714
Other (OTH)
AF:
0.749
AC:
45195
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
14925
29851
44776
59702
74627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20164
40328
60492
80656
100820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.720
AC:
109467
AN:
152050
Hom.:
39719
Cov.:
32
AF XY:
0.719
AC XY:
53428
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.695
AC:
28821
AN:
41468
American (AMR)
AF:
0.578
AC:
8833
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.789
AC:
2737
AN:
3468
East Asian (EAS)
AF:
0.628
AC:
3237
AN:
5154
South Asian (SAS)
AF:
0.809
AC:
3891
AN:
4808
European-Finnish (FIN)
AF:
0.809
AC:
8577
AN:
10608
Middle Eastern (MID)
AF:
0.861
AC:
253
AN:
294
European-Non Finnish (NFE)
AF:
0.751
AC:
51028
AN:
67950
Other (OTH)
AF:
0.712
AC:
1500
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1552
3103
4655
6206
7758
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.739
Hom.:
148592
Bravo
AF:
0.701
TwinsUK
AF:
0.742
AC:
2751
ALSPAC
AF:
0.742
AC:
2858
ESP6500AA
AF:
0.701
AC:
3087
ESP6500EA
AF:
0.750
AC:
6446
ExAC
AF:
0.728
AC:
88350
Asia WGS
AF:
0.723
AC:
2517
AN:
3478
EpiCase
AF:
0.754
EpiControl
AF:
0.756

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
Glycogen storage disease, type II (6)
-
-
5
not specified (5)
-
1
3
not provided (4)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
1.2
DANN
Benign
0.65
DEOGEN2
Uncertain
0.46
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.026
N
LIST_S2
Benign
0.18
T
MetaRNN
Benign
0.0000010
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.0
L
PhyloP100
-1.1
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.010
N
REVEL
Benign
0.16
Sift
Benign
0.59
T
Sift4G
Benign
0.43
T
Polyphen
0.0010
B
Vest4
0.043
MPC
0.088
ClinPred
0.00059
T
GERP RS
-2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.023
gMVP
0.55
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1126690; hg19: chr17-78091405; COSMIC: COSV56407159; COSMIC: COSV56407159; API